Replies to post #56520 on Biotech Values

[DewDiligence]

>MNTA – Proprietary mathematical data integration<

This is the crux of the company’s proprietary technology, IMO.

A lot of people have trouble believing that MNTA can fully characterize a substance as complex as Lovenox. Even Craig Wheeler says he didn’t believe it when he applied for the CEO position.

One reason for the skepticism is that people are looking at the problem backwards: they think that MNTA claims the ability to “rule in” a structural component of an observed compound when in reality what MNTA claims is the ability to rule out a structure as described in #msg-25375908.

[dewophile]

MNTA
i read the website too. they claim they have proprietary enzymes, but what exactly can they do that others can't? I know - its proprietary, so they won't say..

they claim they can analyze a complex carbohydrate structure in ways others can't, but will this translate to a unique ability to convince regulatory authorities that they can demonstrate equivalence to a branded product in ways others can't?

they definitely seem to have a strong grasp of structure/function relationships, and I found the paper on a rationally designed anticoagulant with optimized Xa/II activity quite compelling, so i do think M118 is for real

i hope it turns out to be a winner for you - the potential is definitely there

[DewDiligence]

This capsule summary, which is referenced by the ReadMeFirst, ought to be updated to include the latest issued patents. Would anyone like to volunteer?